Table of Contents Table of Contents
Previous Page  26 / 71 Next Page
Information
Show Menu
Previous Page 26 / 71 Next Page
Page Background

500 

M

astovska

et al

.

:

J

ournal of

AOAC I

nternational

V

ol

. 98, N

o

. 2, 2015

Table 10. Collaborative study results (in µg/kg) obtained by the participating laboratories in blind duplicates fortified at the

mid PAH level in oyster

Laboratory No.

PAH

Sample ID

1

2

3

4

5

6

7

8

9

1,7-DMP

SFC O1

96.8

a

81.8

69.8

40.2

63.5

56.5

75.6

74.5

78.2

SFC O7

31.3

a

80.0

82.6

47.5

71.7

61.6

76.9

73.7

69.8

1-MN

SFC O1

84.8

86.4

109.9

35.5

75.9

96.1

107.4

102.2

45.4

SFC O7

79.3

116.3

152.8

104.4

77.8

100.9

101.2

111.3

46.0

1-MP

SFC O1

500.3

a

40.9

45.4

24.2

37.8

37.2

47.0

48.5

30.5

SFC O7

91.8

a

44.7

48.7

31.1

42.3

37.3

44.2

46.9

31.3

2,6-DMN

SFC O1

573.4

a

71.6

54.5

14.6

a

53.0

46.2

64.0

63.9

50.9

SFC O7

179.1

a

84.1

56.2

93.4

a

58.4

49.1

58.3

54.9

45.2

3-MC

SFC O1

73.9

89.6

94.0

57.5

72.3

83.8

88.7

83.2

67.5

SFC O7

75.8

79.1

98.6

74.5

74.8

82.3

83.9

86.6

69.8

Ant

SFC O1

21.9

a

11.0

11.9

1.7

1.5

8.5

13.7

6.2

11.0

b

SFC O7

6.4

a

9.4

13.0

1.8

0.5

7.2

12.6

6.6

24.8

b

BaA

SFC O1

15.6

20.6

19.6

10.3

12.9

19.3

21.9

18.5

15.4

SFC O7

15.3

19.6

21.1

12.8

11.4

18.4

20.3

19.0

16.9

BaP

SFC O1

3.4

7.0

5.7

2.7

2.8

3.1

9.0

4.7

5.6

SFC O7

2.9

5.7

6.3

3.2

3.0

2.7

8.2

5.0

5.8

BbF

SFC O1

21.3

28.7

26.1

18.5

22.8

28.3

27.0

24.7

21.4

SFC O7

23.2

26.1

27.4

23.9

23.6

25.9

25.0

25.9

22.1

BghiP

SFC O1

6.5

9.8

8.6

5.9

7.3

8.8

9.4

8.7

8.8

SFC O7

6.7

8.2

9.4

7.7

7.5

8.5

9.0

9.0

7.5

BkF

SFC O1

13.9

19.8

19.6

12.2

15.1

19.0

18.1

17.2

14.0

SFC O7

14.2

18.4

19.9

15.9

16.0

21.0

17.1

17.7

14.3

Chr

SFC O1

75.1

93.0

87.7

61.2

74.7

87.9

89.8

85.8

71.7

SFC O7

75.4

84.6

93.1

78.3

79.2

86.4

83.8

87.1

73.5

DBahA

SFC O1

6.9

10.4

8.6

6.2

7.3

8.5

9.5

8.7

11.3

a

SFC O7

7.0

8.5

9.2

7.4

7.5

8.3

8.9

8.6

7.3

a

Fln

SFC O1

18.1

25.1

22.5

14.6

16.8

18.0

23.2

21.5

19.7

SFC O7

17.8

23.1

24.2

18.2

18.7

18.0

21.7

21.4

22.4

Flt

SFC O1

42.0

46.5

44.4

23.0

37.4

58.4

47.5

42.4

33.0

SFC O7

40.6

43.1

47.2

40.0

40.5

47.2

42.8

45.4

34.0

IcdP

SFC O1

6.9

9.9

9.0

6.1

6.9

9.1

9.4

8.8

9.7

SFC O7

6.9

8.8

9.5

7.8

7.7

8.2

8.7

8.9

7.8

Naph

SFC O1

89.8

118.9

110.0

77.4

87.6

112.1

117.3

115.8

113.6

SFC O7

82.6

112.8

125.0

101.6

88.4

113.9

110.2

117.7

116.4

Phe

SFC O1

65.0

96.6

87.5

58.3

76.0

71.8

89.9

89.1

75.3

SFC O7

68.1

87.2

93.6

77.9

84.0

72.0

83.8

88.3

81.7

Pyr

SFC O1

59.2

71.1

68.8

45.2

a

55.2

64.9

69.3

64.6

56.2

SFC O7

57.8

65.9

70.5

59.1

a

59.4

62.8

64.6

63.6

57.9

a

Outliers removed by the Cochran test.

b

Removed due to the reported integration issues.